Harbor Capital Advisors Inc. Raises Stock Position in Cellebrite DI Ltd. (NASDAQ:CLBT)

Harbor Capital Advisors Inc. boosted its position in Cellebrite DI Ltd. (NASDAQ:CLBT) by 65.4% during the 4th quarter, HoldingsChannel.com reports. The firm owned 157,671 shares of the company’s stock after purchasing an additional 62,320 shares during the quarter. Harbor Capital Advisors Inc.’s holdings in Cellebrite DI were worth $3,473,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. TD Asset Management Inc purchased a new stake in shares of Cellebrite DI in the second quarter worth $121,000. Y.D. More Investments Ltd bought a new stake in shares of Cellebrite DI during the 2nd quarter valued at about $347,000. Renaissance Technologies LLC grew its holdings in shares of Cellebrite DI by 22.1% during the second quarter. Renaissance Technologies LLC now owns 1,183,700 shares of the company’s stock worth $14,145,000 after purchasing an additional 214,600 shares in the last quarter. Connors Investor Services Inc. purchased a new position in shares of Cellebrite DI during the second quarter worth about $1,803,000. Finally, Hsbc Holdings PLC increased its position in shares of Cellebrite DI by 44.7% in the second quarter. Hsbc Holdings PLC now owns 238,002 shares of the company’s stock worth $2,866,000 after purchasing an additional 73,533 shares during the last quarter. 45.88% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of research firms have commented on CLBT. Craig Hallum boosted their price target on shares of Cellebrite DI from $23.00 to $24.00 and gave the stock a “buy” rating in a research note on Thursday, November 7th. Needham & Company LLC raised their price target on Cellebrite DI from $17.00 to $21.00 and gave the company a “buy” rating in a research report on Thursday, November 7th. JPMorgan Chase & Co. upped their price objective on Cellebrite DI from $22.00 to $24.00 and gave the stock an “overweight” rating in a report on Monday, December 16th. Finally, TD Cowen raised their price objective on Cellebrite DI from $20.00 to $23.00 and gave the company a “buy” rating in a report on Monday, September 23rd. Eight equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average price target of $20.57.

Cellebrite DI Stock Performance

Shares of CLBT stock opened at $21.57 on Friday. Cellebrite DI Ltd. has a fifty-two week low of $7.91 and a fifty-two week high of $22.91. The company has a market capitalization of $4.44 billion, a P/E ratio of -13.92, a PEG ratio of 2.71 and a beta of 1.46. The stock has a 50 day moving average price of $20.39 and a two-hundred day moving average price of $17.19.

Cellebrite DI (NASDAQ:CLBT) last posted its earnings results on Wednesday, November 6th. The company reported $0.14 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.09 by $0.05. The business had revenue of $106.90 million for the quarter, compared to analysts’ expectations of $102.06 million. Cellebrite DI had a negative net margin of 82.28% and a positive return on equity of 122.59%. The business’s revenue for the quarter was up 27.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.09 EPS. As a group, equities analysts predict that Cellebrite DI Ltd. will post 0.32 earnings per share for the current year.

About Cellebrite DI

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.